immune modulation. Biomaterials 37:333–344.
https://doi.org/10.1016/j.biomaterials.2014.
10.037
3. Li Y, Beitelshees M, Fang L, Ahmadi MK,
Chen M, Hill A, Davidson BA, Knight P 3rd,
Smith RJ Jr, Andreadis ST, Hakansson AP, Jones
CH, Pfeifer BA (2016) In situ pneumococcal
vaccine production and delivery through a
hybrid biological-biomaterial vector. Sci Adv 2
(7):e1600264
4. Samal SK, Dash M, Van Vlierberghe S, Kaplan
DL, Chiellini E, van Blitterswijk C, Moroni L,
Dubruel P (2012) Cationic polymers and their
therapeutic potential. Chem Soc Rev 41
(21):7147–7194. https://doi.org/10.1039/
c2cs35094g
5. Qiao Y, Huang Y, Qiu C, Yue X, Deng L, Wan Y,
Xing J, Zhang C, Yuan S, Dong A, Xu J (2009)
The use of PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as a mucosal DNA
delivery vector and the activation of innate
immunity and improvement of HIV-1-specific
immune
responses.
Biomaterials
31
(1):115–123.
https://doi.org/10.1016/j.
biomaterials.2009.09.032
6. Jones CH, Chen M, Gollakota A,
Ravikrishnan A, Zhang G, Lin S, Tan M,
Cheng C, Lin H, Pfeifer BA (2015) Structurefunction assessment of mannosylated poly
(β-amino esters) upon targeted antigen presenting cell gene delivery. Biomacromolecules 16
(5):1534–1541. https://doi.org/10.1021/acs.
biomac.5b00062
7. Jones CH, Gollakota A, Chen M, Chung T-C,
Ravikrishnan A, Zhang G, Pfeifer BA (2015)
Influence of molecular weight upon mannosylated bio-synthetic hybrids for targeted antigen
presenting cell gene delivery. Biomaterials
58:103–111.
https://doi.org/10.1016/j.
biomaterials.2015.04.033
8. Jones CH, Chen C-K, Ravikrishnan A, Rane S,
Pfeifer BA (2013) Overcoming nonviral gene
delivery barriers: perspective and future. Mol
Pharm 10(11):4082–4098. https://doi.org/
10.1021/mp400467x
9. Beitelshees M, Li Y, Pfeifer BA (2016) Enhancing vaccine effectiveness with delivery technology. Curr Opin Biotechnol 42:24–29. https://
doi.org/10.1016/j.copbio.2016.02.022
Hybrid Biological-Biomaterial Vector
475
https://doi.org/10.1016/j.biomaterials.2014.
10.037
3. Li Y, Beitelshees M, Fang L, Ahmadi MK,
Chen M, Hill A, Davidson BA, Knight P 3rd,
Smith RJ Jr, Andreadis ST, Hakansson AP, Jones
CH, Pfeifer BA (2016) In situ pneumococcal
vaccine production and delivery through a
hybrid biological-biomaterial vector. Sci Adv 2
(7):e1600264
4. Samal SK, Dash M, Van Vlierberghe S, Kaplan
DL, Chiellini E, van Blitterswijk C, Moroni L,
Dubruel P (2012) Cationic polymers and their
therapeutic potential. Chem Soc Rev 41
(21):7147–7194. https://doi.org/10.1039/
c2cs35094g
5. Qiao Y, Huang Y, Qiu C, Yue X, Deng L, Wan Y,
Xing J, Zhang C, Yuan S, Dong A, Xu J (2009)
The use of PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as a mucosal DNA
delivery vector and the activation of innate
immunity and improvement of HIV-1-specific
immune
responses.
Biomaterials
31
(1):115–123.
https://doi.org/10.1016/j.
biomaterials.2009.09.032
6. Jones CH, Chen M, Gollakota A,
Ravikrishnan A, Zhang G, Lin S, Tan M,
Cheng C, Lin H, Pfeifer BA (2015) Structurefunction assessment of mannosylated poly
(β-amino esters) upon targeted antigen presenting cell gene delivery. Biomacromolecules 16
(5):1534–1541. https://doi.org/10.1021/acs.
biomac.5b00062
7. Jones CH, Gollakota A, Chen M, Chung T-C,
Ravikrishnan A, Zhang G, Pfeifer BA (2015)
Influence of molecular weight upon mannosylated bio-synthetic hybrids for targeted antigen
presenting cell gene delivery. Biomaterials
58:103–111.
https://doi.org/10.1016/j.
biomaterials.2015.04.033
8. Jones CH, Chen C-K, Ravikrishnan A, Rane S,
Pfeifer BA (2013) Overcoming nonviral gene
delivery barriers: perspective and future. Mol
Pharm 10(11):4082–4098. https://doi.org/
10.1021/mp400467x
9. Beitelshees M, Li Y, Pfeifer BA (2016) Enhancing vaccine effectiveness with delivery technology. Curr Opin Biotechnol 42:24–29. https://
doi.org/10.1016/j.copbio.2016.02.022
Hybrid Biological-Biomaterial Vector
475